London Stock Exchange Group

Business news, market intelligence, and global industry analysis.

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

A representative image of a modern financial trading floor and real-time market data screens, reflecting London Stock Exchange Group plc’s strong 2025 results as its shift into a global financial data and infrastructure platform drives higher margins, earnings growth, and record cash generation.

LSEG delivers 50% EBITDA margin and 15.7% earnings growth as Refinitiv transformation reaches full stride

London Stock Exchange Group (LSEG) delivered 7.1% organic revenue growth in 2025, with EBITDA margins hitting 50.3% and a fresh £3bn buyback. Read the full analysis.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

March 1, 2026